LIMAA Technologies GmbH, a spin-off fromCharité, is pioneering a breakthrough platform for digital, AI-supported 3Dhistology. By combining tissue-permeable nanobodies,light-sheet microscopy, and AI-powered support, we set new standards forprecision, efficiency, and automation in cancer diagnostics. Their innovative approach allows for fully automated analysis of wholetissue samples—without embedding, sectioning, or glass slides. Usingproprietary nanobody-based staining and light-sheet microscopy, tissue isdirectly labeled and digitized. AI-powered algorithms assist pathologists inmaking precise and efficient diagnoses.